Regulatory Science Activity Report (FY 2023)

27/28

27 < Editorial Note > s efforts on regulatory science. We will continue to work for enhancing contents of the future report for meeting your expectations. If you have any comments, please contact us at rs-research-toiawasepmda.go.jp (“” is used here to prevent spam mail; please change “” to “@”). < Warning > Secondary use of the content in this document (text, images, etc.) is strictly prohibited without prior permission. < Disclaimer> This report was prepared by translating into English based on the contents of the Japanese version of the report. If there is any conflict or inconsistency between these two reports, the Japanese report shall prevail. < Photos and illustrations provided > Pixta, Inc. < Contact information for this report > Pharmaceuticals and Medical Devices Agency (PMDA) Office of Research Administration Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki, Chiyoda-ku, Tokyo rs-research-toiawasepmda.go.jp (“” is used here to prevent spam mail; please change “” to “@”). We have finally published the first RS activity report. We hope this report is useful for the readers to understand the PMDA’ 〒100-0013